Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Managed Care & Specialty Pharmacy|July 27, 2026
Evaluating the feasibility of health care databases for assessing the safety of switching between originator biologics and biosimilarsAaron B Mendelsohn, Terese A DeFor, Djeneba Audrey Djibo, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Utilization, user characteristics, and adverse outcomes of insulin glargine originators and follow-on drug in patients with diabetes in the United StatesAshish Rai, Young Hee Nam, Aaron B Mendelsohn, et al.The British Journal of Ophthalmology|July 13, 2017
Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2Catherine M Lockhart, Travis B Smith, Paul Yang, et al.Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Transforming retinal disease management through diabetes careCatherine M Lockhart, Mark R Barakat, Jeffrey D Dunn, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2021
BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High-Neutropenia Risk ChemotherapyPamala A Pawloski, Cara L McDermott, James H Marshall, et al.Pharmacology Research & Perspectives|December 29, 2020
Utilization patterns and characteristics of users of biologic anti-inflammatory agents in a large, US commercially insured populationAaron B Mendelsohn, Young Hee Nam, James Marshall, et al.Pharmacoepidemiology and Drug Safety|December 20, 2019
Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare DataMengdong He, Adrian J Santiago Ortiz, James Marshall, et al.Journal of Managed Care & Specialty Pharmacy|February 6, 2025
Patient characteristics and use for bevacizumab in ophthalmology and oncology in a distributed research networkJenice S Ko, Aaron B Mendelsohn, Kimberly Daniels, et al.Journal of Managed Care & Specialty Pharmacy|August 10, 2019
Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to Evaluate Patterns of CareCheryl N McMahill-Walraven, Daniel J Kent, Catherine A Panozzo, et al.Journal of Managed Care & Specialty Pharmacy|August 14, 2019
Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes MellitusDaniel J Kent, Cheryl N McMahill-Walraven, Catherine A Panozzo, et al.Pageof 3